
### [MONDO:0016721](http://purl.obolibrary.org/obo/MONDO_0016721)
**Label:** pineal tumor of neuroepithelial tissue

**Subclasses:** [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), [MONDO:0016724](http://purl.obolibrary.org/obo/MONDO_0016724) (papillary tumor of the pineal region), [MONDO:0016723](http://purl.obolibrary.org/obo/MONDO_0016723) (pineocytoma (disease)), [MONDO:0016725](http://purl.obolibrary.org/obo/MONDO_0016725) (pineal parenchymal tumor of intermediate differenciation), 

**Corr. equiv. classes:** [Orphanet:251909](http://www.orpha.net/ORDO/Orphanet_251909), [Orphanet:251919](http://www.orpha.net/ORDO/Orphanet_251919), [Orphanet:251915](http://www.orpha.net/ORDO/Orphanet_251915), [Orphanet:251912](http://www.orpha.net/ORDO/Orphanet_251912), 

**Class expressions from DL-Learner:**

- [HP:0030531](http://purl.obolibrary.org/obo/HP_0030531) (Altitudinal visual field defect) 75.00%
- [HP:0030693](http://purl.obolibrary.org/obo/HP_0030693) (Supratentorial neoplasm) 62.50%
- [HP:0030692](http://purl.obolibrary.org/obo/HP_0030692) (Brain neoplasm) 62.50%
- [HP:0010799](http://purl.obolibrary.org/obo/HP_0010799) (Pinealoma) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0100576](http://purl.obolibrary.org/obo/HP_0100576) (Amaurosis fugax) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0100012](http://purl.obolibrary.org/obo/HP_0100012) (Neoplasm of the eye) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0030693](http://purl.obolibrary.org/obo/HP_0030693) (Supratentorial neoplasm) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0030692](http://purl.obolibrary.org/obo/HP_0030692) (Brain neoplasm) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0030063](http://purl.obolibrary.org/obo/HP_0030063) (Neuroepithelial neoplasm) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0030061](http://purl.obolibrary.org/obo/HP_0030061) (Neuroectodermal neoplasm) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0030060](http://purl.obolibrary.org/obo/HP_0030060) (Nervous tissue neoplasm) 62.50%
- [HP:0000619](http://purl.obolibrary.org/obo/HP_0000619) (Impaired convergence) and [HP:0012795](http://purl.obolibrary.org/obo/HP_0012795) (Abnormality of the optic disc) 62.50%


